About Novo Nordisk
Novo Nordisk is a healthcare company and a world leader in diabetes care. In addition, Novo Nordisk has a leading position within areas such as haemostasis management, growth hormone therapy and hormone replacement therapy. Novo Nordisk manufactures and markets pharmaceutical products and services that make a significant difference to patients, the medical profession and society.
With headquarters in Denmark, Novo Nordisk employs approximately 21,000 full-time employees in 78 countries, and markets its products in 179 countries.
Novo Nordisk is determined to defeat diabetes, but we recognise that this cannot be done through scientific research and drugs alone. Social leadership is just as important for making a real impact on society’s health. We believe that the best place to begin is by teaching children that a healthy lifestyle can help to prevent the onset of type 2 diabetes and other lifestyle diseases. Novo Nordisk is committed to be a socially responsible company and we encourage our employees to contribute to healthier, greener communities where we can make a difference.
The School Challenge is one of the social initiatives created by Novo Nordisk. You can find out more about Novo Nordisk other initiatives here:
